Transition From Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Ii-Receptor-Blocker to Sacubitril/Valsartan in Chronic Heart Failure Patients: Initial Experiences in Clinical Practice

Cor et Vasa - Poland
doi 10.1016/j.crvasa.2017.10.009

Related search